Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS) Event May 12, 2022, 00:00 UTC 9 1 comments (76% Positive) AKOUOS, INC. (AKUS) Reports 40% Loss Reduction for 2022-03-31 Comment Full text
Cabaletta Bio Inc (CABA) Event May 12, 2022, 00:00 UTC 9 1 comments (61% Neutral) CABALETTA BIO, INC. (CABA) Reports Net Loss for 2022-03-31 Comment Full text
None (GMDA) Event May 12, 2022, 00:00 UTC 9 1 comments (52% Neutral) GAMIDA CELL LTD. (GMDA) Reports Net Loss for 2022-03-31 Comment Full text
Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR) Event May 12, 2022, 00:00 UTC 11 1 comments (75% Positive) TCR2 Therapeutics Inc. (TCRR) Reports Net Loss for 2022-03-31 Comment Full text
Royalty Pharma (RPRX) Event May 11, 2022, 15:32 UTC 17 1 comments (99% Neutral) Royalty Pharma plc (RPRX) Announces Business Combination Comment Full text
Genmab (GMAB) Event May 11, 2022, 15:24 UTC 8 1 comments (30% Negative) Genmab (GMAB) Reports Q2 2022 Financial Results (Form 6-K) Comment Full text
RedHill Biopharma (RDHL) Event May 11, 2022, 12:56 UTC 9 1 comments (99% Neutral) RedHill Biopharma (RDHL) Files Form 6-K Comment Full text
Absci Corporation (ABSI) Event May 11, 2022, 12:15 UTC 13 1 comments (30% Negative) ABSCI CORP (ABSI) Reports Q2 2022 Financial Results Comment Full text
Ovid Therapeutics Inc (OVID) Event May 11, 2022, 12:13 UTC 16 1 comments (10% Negative) OVID THERAPEUTICS INC. (OVID) Announces Clinical Trial Timeline Adjustment Comment Full text
RAPT Therapeutics Inc (RAPT) Event May 11, 2022, 12:10 UTC 19 1 comments (99% Positive tone) RAPT Therapeutics, Inc. (RAPT) Reports Q2 2022 Financial Results Comment Full text